Depression that does not respond to standard treatment can be difficult to manage for many adults. When several medications have been tried without meaningful relief, patients and clinicians often look toward alternative options. Spravato is one such option, and it can be utilized to support a patient’s mental health care.
What Is Spravato?
Spravato is a prescription nasal spray that contains esketamine, and it is approved for use in specific situations related to depression. Unlike medications taken at home on a daily basis, Spravato is administered in a healthcare setting under the direct supervision of a medical professional. The nasal spray delivery method sets it apart from many traditional oral antidepressants. This controlled approach reflects the specialized nature of the medication and the monitoring that accompanies its use.
What Does It Treat?
Spravato is associated with a few areas of depression care. The first is treatment-resistant depression, and this is a term used when a person with major depressive disorder has not responded adequately to at least two different antidepressant medications. In these cases, Spravato may be prescribed alongside an oral antidepressant as part of a broader treatment plan.
The second area involves depressive symptoms in adults with major depressive disorder who experience suicidal thoughts or behavior. In such situations, the medication may be used in conjunction with other care measures. Decisions about whether Spravato is appropriate rest with a healthcare provider; they can evaluate each individual’s medical history and current condition.
What Should You Expect?
The treatment process for Spravato follows a structured routine, designed around safety. Patients self-administer the nasal spray, but they do so under the watchful eye of medical staff at the practice’s location. The clinician provides guidance on how to use the device correctly before the dose is taken.
After administration, patients remain at the facility for a monitoring period that typically lasts around two hours. Staff will observe for possible effects such as changes in blood pressure, drowsiness, or temporary feelings of detachment. This observation window allows the care team to respond promptly if any reaction occurs. The medication can affect alertness and coordination, so patients are advised not to drive or operate machinery on the day of treatment. Arranging transportation home is a standard part of the process.
Sessions are often scheduled more frequently at the start of treatment, and they may become less frequent over time, depending on the individual’s response and the plan set by the treating clinician. Each visit generally follows the same pattern: check-in, supervised administration, and the monitoring period before the patient is cleared to leave. This consistency helps patients understand what to anticipate at every appointment.
Speak Further With a Specialist
Spravato represents a specialized option within the wider field of depression treatment, and its use depends on careful medical judgment. Because it is administered under supervision and forms part of a larger care plan, professional guidance impacts the entire process. A specialist can review your history, explain how Spravato fits alongside other therapies, and outline what a treatment schedule will look like. Speaking with a provider gives you personalized information and helps clarify whether this approach aligns with your needs.
